A. Takada

发表

Pharmacokinetic/pharmacodynamic modeling of roxadustat's effect on LDL cholesterol in patients in Japan with dialysis-dependent chronic kidney disease and anemia.

T. Akizawa, Kanji Komatsu, T. Shibata, 2022, Drug metabolism and pharmacokinetics.

Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes.

M. Katashima, Hiroshi Suzuki, Koji Chono, 2016, Drug metabolism and pharmacokinetics.

A phase I, open-label, single-dose micro tracer mass balance study of 14C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry.

M. Katashima, Naoyuki Nakada, T. Sawamoto, 2018, Drug metabolism and pharmacokinetics.

Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects

M. Katashima, K. Furihata, T. Shibata, 2018, Clinical pharmacology in drug development.

Quantification of ASP2151 in Human Plasma and Urine: A Pitfall Associated with Supersaturation of Analyte in Urine

Yoshiaki Ohtsu, D. Groenendaal, A. Takada, 2017, Chromatographia.

The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies

M. Katashima, R. Preston, D. Kowalski, 2017, Advances in Therapy.

Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder.

M. Katashima, Kanji Komatsu, A. Takada, 2020, Clinical therapeutics.

Population pharmacokinetic modeling of Sepantronium bromide (YM155), a small molecule survivin suppressant, in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanoma

M. Katashima, Y. Aoyama, T. Sawamoto, 2012, Investigational New Drugs.

Evaluation of the effect of lanthanum carbonate hydrate on the pharmacokinetics of roxadustat in non‐elderly healthy adult male subjects

M. Katashima, T. Shibata, A. Takada, 2018, Journal of clinical pharmacy and therapeutics.

An Open‐Label, Single‐Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults

M. Katashima, Yoshiaki Ohtsu, A. Takada, 2018, Clinical pharmacology in drug development.

Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

D. Kaufman, P. Smith, G. Kearns, 2009, The Pediatric infectious disease journal.

Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression.

M. Katashima, Kanji Komatsu, A. Takada, 2020, Clinical therapeutics.

Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies

M. Katashima, Yoshiaki Ohtsu, D. Kowalski, 2017, Advances in Therapy.

Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non‐linear effect model for the treatment of genital herpes

M. Katashima, J. Keirns, Wenhui Zhang, 2014, Clinical pharmacology in drug development.

Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults

M. Katashima, Yoshiaki Ohtsu, A. García-Hernandez, 2017, Advances in Therapy.

Population pharmacokinetics of roxadustat in Japanese dialysis‐dependent chronic kidney disease patients with anaemia

Kanji Komatsu, T. Shibata, A. Takada, 2021, British journal of clinical pharmacology.

Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

D. Kaufman, P. Smith, G. Kearns, 2009, The Pediatric infectious disease journal.